Pharma & Life Sciences

Annual Neuropsychiatric Drug Development Summit

The Annual Neuropsychiatric Drug Development Summit is a premier event dedicated to advancing the field of neuropsychiatric research and drug development.

6 weeks until it opens.

The essentials

Event details

Dates
15 September 2026 to 17 September 2026
Organiser
9th Neuropsychiatric Drug Development Summit 2026
Expected attendance
28
Industry
Pharma & Life Sciences

Agenda themes

Topics covered

  • Medical & Pharma

On stage

Speakers

  • Derek Buhl, Scientific Director, AbbVie
  • Guy Goodwin, CMO, Compass Pathways
  • Nick Brandon, Chief Scientific Officer, Neumora
  • Pranah Kalita, Boehri

On the floor

Sponsors and partners

  • Cognison
  • Transpharmation
  • Ulysses Neurosciences
  • Clerkenwell Health
  • Sama Therapeutics
  • BioTrial
  • Eurofins
  • SynapCell
  • Beacon Psychiatry

Logistics

Where to stay

Places to stay near the venue.

Keep planning

Related events

Spot something wrong on this page? Report a correction and we will fix it.